Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018145365) DEVICE FOR TREATMENT OF VALVE REGURGITATION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/145365 International Application No.: PCT/CN2017/084157
Publication Date: 16.08.2018 International Filing Date: 12.05.2017
IPC:
A61F 2/24 (2006.01) ,A61B 17/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
F
FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
2
Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
02
Prostheses implantable into the body
24
Heart valves
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
B
DIAGNOSIS; SURGERY; IDENTIFICATION
17
Surgical instruments, devices or methods, e.g. tourniquets
Applicants:
上海甲悦医疗器械有限公司 SHANGHAI JOY MEDICAL DEVICES CO., LTD. [CN/CN]; 中国上海市 浦东新区康新公路3399弄25号702室 Room 702, Building 25 3399# KangXinGongLu, PuDong New district Shanghai 201321, CN
Inventors:
李守彦 LEE, Shouyan; US
南红霞 NAN, Hongxia; CN
Agent:
北京市隆安律师事务所 BEIJING LONGAN LAW FIRM; 中国北京市 朝阳区建国门外大街21号北京国际俱乐部188室 Room 188, Beijing International Club 21 Jianguomenwai Street, Chaoyang District Beijing 100020, CN
Priority Data:
PCT/CN2017/07306907.02.2017CN
Title (EN) DEVICE FOR TREATMENT OF VALVE REGURGITATION
(FR) DISPOSITIF DE TRAITEMENT DE LA RÉGURGITATION VALVULAIRE
(ZH) 治疗瓣膜反流的装置
Abstract:
(EN) A device for treatment of valve regurgitation, comprising frameworks (114, 133, 141, 701, 812, 821, 911) and an anchoring unit (132). The anchoring unit (132) is connected to the frameworks (114, 133, 141, 701, 812, 821, 911); the frameworks (114, 133, 141, 701, 812, 821, 911) can be expanded and compressed and have an inflow end (421) and an opposite outflow end (422); valve leaflets (142, 621, 721, 751) capable of opening and closing in blood flow are provided inside the frameworks (114, 133, 141, 701, 812, 821, 911); the anchoring unit (132) can keep the frameworks (114, 133, 141, 701, 812, 821, 911) in an expanded state at the orifice position of a natural heart valve. The device for treatment of valve regurgitation and an implantation method therefor can effectively treat valve regurgitation. The device positions accurately and firmly, and would not adhere to a natural valve annulus or obstruct the blood flow in heart. Moreover, the device is recyclable, has high operability and security in minimally invasive repair, and has high clinical value.
(FR) L'invention concerne un dispositif de traitement de la régurgitation valvulaire, comprenant des structures (114, 133, 141, 701, 812, 821, 911) et une unité d'ancrage (132). L'unité d'ancrage (132) est reliée aux structures (114, 133, 141, 701, 812, 821, 911); les structures (114, 133, 141, 701, 812, 821, 911) peuvent être étendues et comprimées et ont une extrémité d'entrée (421) et une extrémité de sortie opposée (422); des feuillets de valvule (142, 621, 721, 751) pouvant s'ouvrir et se fermer dans le flux sanguin sont prévus à l'intérieur des structures (114, 133, 141, 701, 812, 821, 911); l'unité d'ancrage (132) peut maintenir les structures (114, 133, 141, 701, 812, 821, 911) dans un état déployé au niveau de la position d'orifice d'une valve cardiaque naturelle. Le dispositif de traitement de la régurgitation valvulaire et son procédé d'implantation peuvent traiter efficacement la régurgitation valvulaire. Le dispositif se positionne avec précision et fermement, et n'adhère pas à un anneau de valve naturel ou obstrue le flux sanguin dans le cœur. De plus, le dispositif est recyclable, a une exploitabilité et une sécurité élevées dans une réparation minimalement invasive, et a une valeur clinique élevée.
(ZH) 一种用于治疗瓣膜反流的装置,包括框架(114,133,141,701,812,821,911)和锚定装置(132),锚定装置(132)与框架(114,133,141,701,812,821,911)连接;框架(114,133,141,701,812,821,911)可扩张压缩,具有流入端(421)和相对的流出端(422);框架(114,133,141,701,812,821,911)的内部设置有可在血液流动中打开关闭的瓣膜小叶(142,621,721,751);锚定装置(132)能够保持扩张状态下的框架(114,133,141,701,812,821,911)在心脏原生瓣膜的孔口位置。治疗瓣膜反流的装置及其植入方法能有效治疗瓣膜反流,装置定位准确且牢固,不会与原生瓣环发生粘连,对心脏内血液流动无阻塞,而且装置可回收,具有微创修复可操作性强、安全性高的特点,具有极高的临床价值。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)